|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Pharmaceutical firms are known for their large investments in aggressive and sophisticated marketing, which can easily exceed $50 million for many brand name drugs. Yet is the firm receiving the revenue that the brand is attracting or is it going to counterfeiters, disloyal distributors and other criminals? For example, a drug that drives $500 million in annual revenues and has a conservative five per cent counterfeiting and/or diversion problem, is losing $25 million in top line revenue. The stakes are even higher for the more than 20 drugs that bring in annual sales of one billion plus each year, especially since these drugs tend to have the cache and profit margins that counterfeiters covet.
The pharmaceutical industry also has the added burden of liability and consumer confidence obligations as Figure 1, Figure 2 and Figure 3 detail. Loss of revenue due to product and brand compromise is no longer an accepted cost when doing business. As detailed in previous PMPS articles, there are a number of commercially available technologies each with properties that make them well suited for combating fraud in different applications. Figure 3 illustrates some of the key features of the different technologies and most importantly, the ease with which they can be copied or counterfeited. Interestingly enough, those with some of the most sophisticated security features are not necessarily the most expensive on a per unit basis.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
BioPharm America
15-17 September 2010, San Francisco, US
BioPharm America™ is where biotech industry partnerships get started. Meet one-to-one with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE™, the world’s leading partnering system for the life science industry, BioPharm America is the only event in North America based on the same proven formula as EBD Group’s acclaimed European events BIO-Europe and BIO-Europe Spring®.
More info >> |
|
 |
News and Press Releases |
 |
PharmaBrand Summit 2010
Top pharmaceutical executives shared best practices at the PharmaBrand Summit
2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco
and was organised by Marcus Evans
More info >> |
|
 |
